Kineta Prices 890K Share Offering at $3.37/sh
Kineta, Inc. (Nasdaq: KA) announced today that it has entered into a definitive agreement for the purchase and sale of 890,208 shares of the Company’s common stock (or pre-funded warrants in...
Buy
or
Kineta News & Analysis
-
-
Kineta Reports Positive KVA12123 Monotherapy Safety and Biomarker Data
Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today an...
-
Kineta to Receive $5M Milestone Payment from Merck
Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today the...
-
Kineta to Join Russell Microcap Index
Kineta, Inc. (Nasdaq: KA) announced today that the company is set to join the Russell Microcap® Index at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the...
-
Kineta earnings beat by $0.38, revenue fell short of estimates
Investing.com - Kineta (NASDAQ: KA) reported first quarter EPS of $-0.77, $0.38 better than the analyst estimate of $-1.15. Revenue for the quarter came in at $280K versus the consensus...
-
Kineta Announces $6 Million Registered Direct Offering of Common Stock, Warrants
Kineta, Inc. (Nasdaq: KA) (the “Company” or “Kineta”), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune...
-
Kineta Unveils New VISTA Biomarker Data, Provides KVA12123 Phase 1/2 Clinical Trial Update
Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today the...
-
Kineta Announces Doses First Patient in Phase 1/2 Clinical Study of KVA12123
Kineta, Inc. (Nasdaq: KA) announced today the first patient has been dosed in a Phase 1/2 clinical study evaluating KVA12123 alone and in combination with the immune checkpoint inhibitor...
-
Kineta Announces Board Changes
Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on developing next-generation immunotherapies to address cancer immune resistance, announced today the appointment...
-
Proteostasis Therapeutics earnings beat, Revenue misses in Q3
Investing.com - Proteostasis Therapeutics reported on Monday third quarter {{erl-963705||earnings that beat analysts' forecasts and revenue that fell short of expectations. Proteostasis...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.58%
Investing.com – U.S. equities were lower at the close on Monday, as losses in the Consumer Services, Financials and Technology sectors propelled shares lower. At the close in NYSE, the Dow...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 1.78%
Investing.com – U.S. equities were lower at the close on Thursday, as losses in the Technology, Financials and Industrials sectors propelled shares lower. At the close in NYSE, the Dow...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.59%
Investing.com – U.S. equities were lower at the close on Wednesday, as losses in the Oil & Gas, Technology and Consumer Services sectors propelled shares lower. At the close in NYSE, the...
-
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.70%
Investing.com – U.S. equities were higher at the close on Wednesday, as gains in the Oil & Gas, Financials and Consumer Goods sectors propelled shares higher. At the close in NYSE, the Dow...
-
US STOCKS-Wall Street closes higher as recovery signs soothe protest, pandemic worries
(For a live blog on the U.S. stock market, click LIVE/ or type LIVE/ in a news window.) (Updates to market close)By Stephen CulpNEW YORK, June 1 (Reuters) - U.S. stocks posted gains on...
-
US STOCKS-U.S. stocks gain as signs of recovery offset protests, economic worries
(For a live blog on the U.S. stock market, click LIVE/ or type LIVE/ in a news window.)* U.S. factory activity eases off an 11-year low in May* Target , Walmart (NYSE:WMT) shut stores as...
-
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.11%
Investing.com – U.S. equities were higher at the close on Tuesday, as gains in the Consumer Services, Utilities and Basic Materials sectors propelled shares higher. At the close in NYSE,...
-
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.10%
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Basic Materials, Financials and Technology sectors propelled shares higher. At the close in NYSE, the Dow...
-
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.06%
Investing.com – U.S. equities were mixed at the close on Monday, as gains in the Consumer Goods, Consumer Services and Industrials sectors propelled shares higher while losses in the...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 1.27%
Investing.com – U.S. equities were lower at the close on Thursday, as losses in the Technology, Industrials and Consumer Services sectors propelled shares lower. At the close in NYSE, the...
-
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.38%
Investing.com – U.S. equities were mixed at the close on Thursday, as gains in the Oil & Gas, Telecoms and Utilities sectors propelled shares higher while losses in the Technology, Basic...
-
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.47%
Investing.com – U.S. equities were higher at the close on Tuesday, as gains in the Oil & Gas, Consumer Services and Industrials sectors propelled shares higher. At the close in NYSE, the...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.68%
Investing.com – U.S. equities were lower at the close on Tuesday, as losses in the Technology, Financials and Oil & Gas sectors propelled shares lower. At the close in NYSE, the Dow Jones...
-
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.06%
Investing.com – U.S. equities were mixed at the close on Thursday, as gains in the Telecoms, Oil & Gas and Financials sectors propelled shares higher while losses in the Utilities, Basic...
-
U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.49%
Investing.com – U.S. equities were mixed at the close on Tuesday, as gains in the Telecoms, Financials and Healthcare sectors propelled shares higher while losses in the Utilities,...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.31%
Investing.com – U.S. equities were lower at the close on Friday, as losses in the Telecoms, Financials and Consumer Goods sectors propelled shares lower. At the close in NYSE, the Dow Jones...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.16%
Investing.com – U.S. equities were lower at the close on Thursday, as losses in the Industrials, Consumer Goods and Consumer Services sectors propelled shares lower. At the close in NYSE,...
-
U.S. shares lower at close of trade; Dow Jones Industrial Average down 1.50%
Investing.com – U.S. equities were lower at the close on Monday, as losses in the Basic Materials, Oil & Gas and Financials sectors propelled shares lower. At the close in NYSE, the Dow...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
